Tirzepatide, this novel medication, is sparking considerable buzz within the medical community. It functions differently from traditional diabetes medications, targeting both receptors involved in glucose regulation and satiety. Initial research have demonstrated remarkable efficacy in reducing blood levels in individuals with adult-onset diabetes